US equities
|
NVDA
$236.85
▲+1.24%
SPCX
$165.41
▲+4.05%
MU
$1,064.17
▼-1.00%
TSLA
$377.79
▲+1.94%
MSFT
$526.62
▲+1.76%
INTC
$116.54
▼-2.34%
SNDK
$1,722.03
▲+0.12%
AMD
$628.13
▼-0.91%
NVDA
$236.85
▲+1.24%
SPCX
$165.41
▲+4.05%
MU
$1,064.17
▼-1.00%
TSLA
$377.79
▲+1.94%
MSFT
$526.62
▲+1.76%
INTC
$116.54
▼-2.34%
SNDK
$1,722.03
▲+0.12%
AMD
$628.13
▼-0.91%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Skye Bioscience, Inc. - Common Stock
(NQ:
SKYE
)
1.710
+0.030 (+1.79%)
Delayed Quote
Updated: 10:05 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Skye Bioscience, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing
December 15, 2025
From
Berger Montague
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
December 12, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
December 12, 2025
From
Schall Law
Via
GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
December 09, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
December 09, 2025
From
Schall Law
Via
GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
December 05, 2025
From
Schall Law
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Urges DeFi, Skye Bioscience, and Perrigo Investors to Contact the Firm Regarding their Rights
December 03, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
December 03, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
December 02, 2025
From
Schall Law
Via
GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
November 30, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
↗
November 29, 2025
Here's why a fast-rising pharmaceutical trimmed—and not abandoned—by a specialist fund signals ongoing conviction in the stock.
Via
The Motley Fool
Topics
Regulatory Compliance
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
November 29, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm
November 28, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 28, 2025
From
Schall Law
Via
GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
November 26, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SKYE
November 26, 2025
From
The DJS Law Group
Via
Business Wire
SKYE Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Skye Bioscience, Inc. Class Action Lawsuit
November 25, 2025
From
Robbins LLP
Via
GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 25, 2025
From
Schall Law
Via
GlobeNewswire
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE
November 25, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE
November 25, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Stockholders Spirit, Molina, Skye, and Perrigo of the Upcoming Deadlines and Urges Investors to Contact the Firm
November 24, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
November 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
November 24, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Skye Bioscience to Participate in Upcoming Investment Conferences
November 24, 2025
San Diego, California--(Newsfile Corp. - November 24, 2025) - Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye"), a clinical-stage biotechnology company focused...
Via
Newsfile
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 21, 2025
From
Schall Law
Via
GlobeNewswire
SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
November 20, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm
November 18, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit With the Schall Law Firm
November 18, 2025
From
The Schall Law Firm
Via
Business Wire
SKYE Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against Skye Bioscience, Inc.
November 18, 2025
From
Robbins LLP
Via
GlobeNewswire
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?
↗
November 18, 2025
One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the company’s clinical-stage future.
Via
The Motley Fool
Topics
Regulatory Compliance
< Previous
1
2
3
4
Next >
